Background illustration for clinical trials search

Paid Clinical Trials Dover

Discover 249 paid clinical trials in Dover, Delaware. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Pain and Split-belt Motor Learning in Older Adults

for
Aging, Older Adults, Pain, Motor Learning
Location: Newark DE
Sponsor: University of Delaware

Sex: All

Age: 55 - 70+

Code: NCT07054840

Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Newark DE, Philadelphia PA, Baltimore MD,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase3, Recruiting

Determinants of Changes in Arterial Load Following Exercise

for
Post-Exercise Hypotension
Location: Newark DE
Sponsor: University of Delaware

Sex: All

Age: 18 - 45

Code: NCT05820243

Recruiting

Dietary Sodium, Oxidative Stress, and Pulsatile Hemodynamics

for
Sodium Excess
Location: Newark DE
Sponsor: University of Delaware

Sex: All

Age: 21 - 45

Code: NCT04233957

Recruiting

Mitochondrial Oxidative Stress and Vascular Health in Chronic Kidney Disease

for
Chronic Kidney Disease
Location: Newark DE
Sponsor: University of Delaware

Sex: All

Age: 18+

Code: NCT02364648

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Mechanical Perturbation Training for ACL Injury Prevention

for
Anterior Cruciate Ligament Injury, ACL
Location: Newark DE
Sponsor: University of Delaware

Sex: Female

Age: 15 - 30

Code: NCT03080402

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Newark DE, Camden NJ, York PA, Bethesda MD, Fairfax VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase3, Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Newark DE, Baltimore MD, Lancaster PA, Brandywine MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase3, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Newark DE, Arlington VA, New Brunswick NJ, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase3, Recruiting

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

for
Gastroesophageal Adenocarcinoma
Location: Newark DE, Washington D.C. DC, New York NY, Montreal,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07069712

Phase2, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Newark DE, Pomona NJ, Philadelphia PA,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Newark DE, Baltimore MD, Camden NJ, York PA, Fairfax VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

for
Carcinoma, Non-Small Cell Lung
Location: Newark DE, Philadelphia PA, Towson MD, Silver Spring MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06868277

Phase3, Recruiting

Vitamin D for Prostate Endocrine Therapy

for
Stage I Prostate Cancer AJCC v8,
Location: Newark DE, Wilkes-Barre PA, Mechanicsville VA,
Sponsor: University of Rochester

Sex: Male

Age: 50+

Code: NCT05838716

Phase3, Recruiting

Statins and Breast Cancer Biomarkers

for
Breast Cancer
Location: Newark DE, Durham NC, Goldsboro NC, Boston MA,
Sponsor: University of Vermont

Sex: Female

Age: 35 - 55

Code: NCT00914017

Phase2, Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Newark DE, New York NY, Hackensack NJ, The Bronx NY,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT05544019

Phase1, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Newark DE, Philadelphia PA, Baltimore MD,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase3, Recruiting

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
Relapsed/Refractory Acute Myeloid Leukemia
Location: Newark DE, Canton OH, Atlanta GA, Houston TX, Aurora CO,
Sponsor: Nerviano Medical Sciences

Sex: All

Age: 18+

Code: NCT06549790

Phase1, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Newark DE, Philadelphia PA, Silver Spring MD, York PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase3, Recruiting

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

for
Multiple Myeloma
Location: Newark DE, Columbia MD, Fairfax VA, Elizabeth City NC,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05972135

Phase2, Recruiting